This article is a correction to:
Editorial: Metabolic modulation of cellular function
Or Kakhlon
Ann Saada2,3- 1Department of Neurology, The Anges Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
- 2Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
- 3Department of Genetic and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
- 4Laminar Pharmaceuticals, Palma de Mallorca, Spain
- 5Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain
A Corrigendum on
Editorial: Metabolic modulation of cellular function
by Kakhlon O, Saada A and Escriba PV (2024). Front. Cell Dev. Biol. 12:1395922. doi: 10.3389/fcell.2024.1395922
In the published article, there was an error in the Affiliation list. Instead of “1Hadassah Medical Center, Jerusalem, Israel, 2University of the Balearic Islands”, it should be:
“1Department of Neurology, The Anges Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
2Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
3Department of Genetic and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
4Laminar Pharmaceuticals, Palma de Mallorca, Spain
5Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.”
In the published article there was an error in the Conflict of interest section. It was missing the mention of Laminar Pharmaceuticals. This should have been written as:
Conflict of interest
“Author PE was employed by Laminar Pharmaceuticals.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: metabolism, metabolic pathways, drug discovery, cell fate, metabolomics
Citation: Kakhlon O, Saada A and Escriba PV (2024) Corrigendum: Editorial: Metabolic modulation of cellular function. Front. Cell Dev. Biol. 12:1403128. doi: 10.3389/fcell.2024.1403128
Received: 18 March 2024; Accepted: 26 March 2024;
Published: 11 April 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Kakhlon, Saada and Escriba. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Or Kakhlon, b3JrQGhhZGFzc2FoLm9yZy5pbA==